http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2228824-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-87
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L21-00
filingDate 2001-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcdefeccbb19703e609c591b5f35f7d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fab9bd5f2956a73ab96a12ae41662b6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75f07838a8a23c74523afb6436a2ab3
publicationDate 2005-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2228824-T3
titleOfInvention PURE CITALOPRAM PREPARATION METHOD.
abstract A process for preparing citalopram ** (Formula) ** in which a compound of formula II ** (Formula) ** in which Z is iodine, bromine, chlorine or CF3- (CF2) n-SO2-O-, where n 0, 1, 2, 3, 4, 5, 6, 7 or 8, is subjected to a cyanide exchange reaction with a cyanide source; The resulting crude citalopram product is optionally subjected to initial purification and then treated with an amide group forming agent or similar to amide chosen from the agents of Formulas (a), (b) or (c): ** ( Formulas) ** where X is halogen or an O-CO-R ¿group, Hal is halogen, Y is O or S, W is O, N or S and R, R¿, R¿ and R¿ are chosen each independently from the group consisting of hydrogen, alkyl and aryl or optionally substituted aralkyl; The reaction mixture is then subjected to an acid / base wash and / or crystallization and recrystallization of citalopram in order to remove the amides formed from the crude citalopram mixture; and the resulting citalopram product is optionally purified more intensely, and is then processed and isolated as a base or as a pharmaceutically acceptable salt thereof.
priorityDate 2000-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448525428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3020376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12986614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412550040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448937879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426304417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21888459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10150457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425755001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426155696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450926304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2736962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447856775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416161973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408

Total number of triples: 56.